High mobility group proteins 1 and 2 recognize chromium-damaged DNA

Area of Science:

• Environmental Toxicology
• Molecular Biology
• Carcinogenesis

Background:

• Chromium (Cr) is recognized as a human carcinogen.
• Chromium compounds are potent DNA damaging agents, posing significant health risks.
• Understanding the molecular mechanisms of chromium-induced DNA damage is crucial for risk assessment.

Purpose of the Study:

• To investigate the interaction between chromium (Cr) and DNA.
• To determine if specific DNA-binding proteins recognize chromium-damaged DNA.
• To elucidate the potential role of these proteins in cellular responses to chromium exposure.

Main Methods:

• Incubation of DNA with varying concentrations of chromium chloride (CrCl3).
• Assessment of chromium binding to DNA using electrophoretic mobility shift assays.
• Analysis of high mobility group (HMG) proteins 1 and 2 binding to chromium-damaged DNA (Cr-DNA).
• Determination of binding affinity (Kd) for HMG2 and Cr-DNA.

Main Results:

• Chromium binds to DNA in a dose-dependent manner.
• Chromium exposure alters DNA structure, affecting electrophoretic mobility.
• High mobility group (HMG) proteins 1 and 2 bind to Cr-DNA, with binding intensity correlated to lesion density.
• HMG2 exhibits high affinity binding to Cr-DNA (Kd ~10(-9) M).
• These proteins also bind DNA from chromate-treated cells.

Conclusions:

• Covalent attachment of chromium to DNA induces structural alterations.
• HMG proteins 1 and 2 recognize these chromium-induced DNA structural changes.
• HMG proteins may function as in vivo sensors for Cr-damaged DNA.
• HMG protein binding to Cr-DNA could mediate cellular responses to chromium-DNA adducts.